A controversial but widely-used form of autism treatment, Parsons believed ABA could be an ideal solution, and at first she thought it was effective. ABA helped her mask some of the autistic traits ...

A very influential family with deep political and financial connections to the Sacklers — the owners of Purdue Pharma — the family and company who are named as the driving force in the opioid ...

NASHVILLE, Tenn. (WKRN) — A bipartisan coalition of states, including Tennessee, will receive $7.4 billion from Purdue Pharma, Inc. and members of the Sackler family for their “instrumental ...

A new $7.4 billion settlement with states has been reached with Purdue Pharma and its Sackler family owners. We'll unpack. Most of the money from a newly-reached settlement over the fallout of the ...

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...

In the latest twist in its efforts to wrap up years of high-profile opioid litigation, the billionaire family behind the now-bankrupt Purdue Pharma, the Sacklers, has come back from last year’s ...

Purdue Pharma and its owners, the Sackler family, have negotiated a revised $7.4 billion settlement to resolve litigation over OxyContin's role in the opioid epidemic. This agreement follows the ...

A bipartisan coalition of states has reached a $7.4 billion settlement in principle with members of the Sackler family and their former company Purdue Pharma over their role in the opioid crisis.

The Sacklers and Purdue Pharma boosted their settlement contribution to $7.4 billion after the U.S. Supreme Court overturned a prior settlement in June 2024. If approved, the new plan would end ...